Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04774952
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-20
First Post:
2021-02-25
Brief Title:
Dose Escalation of RMC-5552 Monotherapy in RelapsedRefractory Solid Tumors
Sponsor:
Revolution Medicines Inc
Organization:
Revolution Medicines Inc
Organization Data
Organization:
Revolution Medicines Inc
Class:
INDUSTRY
Study ID:
RMC-5552-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Revolution Medicines Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None